Vor Biopharma Inc (VOR)

Name: Vor Biopharma Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2026-03-31

Latest Quarter

2026-03-31

Revenue

$0.0

Net Income

-$220M

Operating Margin

N/A

Free Cash Flow

-$99.9M

Debt / Assets

32.4%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Vor Biopharma Inc (VOR).
Income Statement (Quarterly)	2026-03-31	2025-03-31	2024-12-31	2024-09-30
Revenue	0	0	0	0
Cost of Revenue	28,000	0	0	0
Gross Profit	-28,000	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	17,537,000	6,590,000	5,963,000	6,696,000
Operating Expenses	35,132,000	33,291,000	31,311,000	28,513,000
Operating Income	-35,160,000	-33,291,000	-31,311,000	-28,513,000
Interest Expense	0	0	0	0
Income Before Tax	-219,585,000	-32,486,000	-30,712,000	-27,559,000
Income Tax Expense	0	0	-899,724	0
Net Income	-219,585,000	-32,486,000	-30,712,000	-27,559,000
Per Share
EPS	-5.11	-0.26	-0.45	-0.40
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Vor Biopharma Inc (VOR).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	0	0	0	0	0
Cost of Revenue	0	3,528,000	3,492,000	8,960,000	0
Gross Profit	0	0	-3,492,000	-8,960,000	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	50,110,000	27,875,000	31,721,000	28,868,000	21,489,000
Operating Expenses	371,642,000	121,185,000	126,036,000	93,418,000	69,018,000
Operating Income	-371,642,000	-121,185,000	-126,036,000	-93,418,000	-69,018,000
Interest Expense	0	0	0	-1,324,000	0
Income Before Tax	-695,981,000	-116,914,000	-117,863,000	-92,094,000	0
Income Tax Expense	0	0	0	-1,324,000	0
Net Income	-695,981,000	-116,914,000	-117,863,000	-90,770,000	0
Per Share
EPS	-70.50	-1.70	-1.75	-2.29	0.00
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Vor Biopharma Inc (VOR).
Balance Sheet (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	81,949,000	31,360,000	57,706,000	119,801,000
Short Term Investments	9,977,000	105,815,000	172,539,000	0
Net Receivables	0	0	0	0
Inventory	0	0	0	0
Total Current Assets	96,507,000	140,803,000	236,950,000	214,399,000
Property Plant Equipment	41,588,000	50,098,000	57,078,000	22,523,000
Goodwill and Intangibles	0	0	0	0
Total Assets	142,891,000	198,126,000	299,366,000	242,590,000
Liabilities
Account Payables	1,505,000	815,000	1,772,000	1,545,000
Short Term Debt	4,215,000	7,660,000	3,272,000	1,839,000
Total Current Liabilities	18,612,000	15,572,000	13,119,000	10,153,000
Long Term Debt	27,615,000	63,660,000	35,640,000	16,174,000
Total Liabilities	46,227,000	47,402,000	48,759,000	26,327,000
Shareholders Equity
Retained Earnings	-456,994,000	-340,080,000	-222,217,000	-130,123,000
Total Shareholders Equity	96,664,000	150,724,000	250,607,000	216,263,000

Balance sheet annual history for Vor Biopharma Inc (VOR).
Balance Sheet (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets
Cash and Cash Equivalents	81,949,000	31,360,000	57,706,000	119,801,000	48,539,000
Short Term Investments	9,977,000	105,815,000	172,539,000	0	0
Net Receivables	0	0	0	0	0
Inventory	0	0	0	0	0
Total Current Assets	96,507,000	140,803,000	236,950,000	214,399,000	49,106,000
Property Plant Equipment	41,588,000	50,098,000	57,078,000	22,523,000	21,845,000
Goodwill and Intangibles	0	0	0	0	0
Total Assets	142,891,000	198,126,000	299,366,000	242,590,000	75,908,000
Liabilities
Account Payables	1,505,000	815,000	1,772,000	1,545,000	2,361,000
Short Term Debt	4,215,000	7,660,000	3,272,000	1,839,000	863,000
Total Current Liabilities	18,612,000	15,572,000	13,119,000	10,153,000	10,207,000
Long Term Debt	27,615,000	63,660,000	35,640,000	16,174,000	17,430,000
Total Liabilities	46,227,000	47,402,000	48,759,000	26,327,000	27,637,000
Shareholders Equity
Retained Earnings	-456,994,000	-340,080,000	-222,217,000	-130,123,000	-61,224,000
Total Shareholders Equity	96,664,000	150,724,000	250,607,000	216,263,000	48,271,000

Cash flow quarterly history for Vor Biopharma Inc (VOR).
Cash Flow Statement (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-116,914,000	-117,863,000	-92,094,000	0
Depreciation & Amortization	3,528,000	3,492,000	2,525,000	0
Stock Based Compensation	9,847,000	13,362,000	10,695,000	0
Change in Working Capital	5,000	650,000	-12,693,000	-9,185,000
Operating Cash Flow	-99,660,000	-100,292,000	-85,144,000	-69,144,000
Investing Activities
Capital Expenditure	-229,000	-1,069,000	-8,462,000	0
Investments	-229,000	-1,069,000	-8,462,000	0
Investing Cash Flow	96,857,000	71,008,000	-94,091,000	-91,651,000
Financing Activities
Debt Repayment	0	0	0	0
Common Stock Issued/Repurchased	55,825,000	2,938,000	115,975,000	0
Dividends Paid	0	0	0	0
Financing Cash Flow	53,392,000	2,938,000	117,140,000	232,911,000
Summary
Free Cash Flow	-99,889,000	-101,361,000	-93,606,000	-69,144,000
Net Change in Cash	50,589,000	-26,346,000	-62,095,000	72,116,000

Cash flow annual history for Vor Biopharma Inc (VOR).
Cash Flow Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Operating Activities
Net Income	-116,914,000	-117,863,000	-92,094,000	0	-43,337,000
Depreciation & Amortization	3,528,000	3,492,000	2,525,000	0	605,000
Stock Based Compensation	9,847,000	13,362,000	10,695,000	0	1,342,000
Change in Working Capital	5,000	650,000	-12,693,000	-9,185,000	4,316,000
Operating Cash Flow	-99,660,000	-100,292,000	-85,144,000	-69,144,000	-36,292,000
Investing Activities
Capital Expenditure	-229,000	-1,069,000	-8,462,000	0	-4,161,000
Investments	-229,000	-1,069,000	-8,462,000	0	-4,161,000
Investing Cash Flow	96,857,000	71,008,000	-94,091,000	-91,651,000	-4,161,000
Financing Activities
Debt Repayment	0	0	0	0	0
Common Stock Issued/Repurchased	55,825,000	2,938,000	115,975,000	0	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	53,392,000	2,938,000	117,140,000	232,911,000	82,526,000
Summary
Free Cash Flow	-99,889,000	-101,361,000	-93,606,000	-69,144,000	-40,453,000
Net Change in Cash	50,589,000	-26,346,000	-62,095,000	72,116,000	42,073,000